High - volume
lung transplant centers have lower
transplantation costs and their patients are less likely to be readmitted within 30 days of leaving the hospital
following surgery, according to a new study of more than 3,000 Medicare patients who received
lung transplants.
Many technological innovations for diagnosis and treatment are expected to reach the clinic
following validation, such as video - assisted thoracic surgery, sensitive imaging techniques, use of tracer gases, regenerative medicine (e.g. in
lung transplantation), nanoparticle - based carriers of inhalational drugs or bioactive compounds, personalised medicine (especially for
lung cancer), bronchoplasty, laser energy as a surgical tool, and metabolic imaging techniques.